ArticleJournal of medicinal chemistry2023

Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer.

Joyeeta Roy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.